Travere Therapeutics Inc. (TVTX)

NASDAQ: TVTX · Real-Time Price · USD

20.81

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

20.23

-2.79%

Pre-market: May 02, 2025, 04:17 AM EDT

Travere Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	233.18M	145.24M	212.02M	227.49M	198.32M	175.34M	164.25M	154.94M	133.59M
Cost of Revenue	7.74M	11.45M	7.59M	6.78M	6.13M	5.23M	5.53M	3.6M	4.55M
Gross Profit	225.43M	133.79M	204.43M	220.71M	192.19M	170.1M	158.72M	151.33M	129.04M
Operating Income	-320.63M	-376.74M	-251.56M	-139.5M	-75.38M	-99.81M	-80.04M	-53.79M	-58.21M
Interest Income	17.82M	21.77M	6.28M	1.99M	5M	10.05M	5.5M	700K	3.98M
Pretax Income	-320.51M	-376.11M	-278.17M	-179.68M	-188.79M	-146.45M	-101.87M	-58.36M	-57.58M
Net Income	-321.55M	-111.4M	-278.48M	-180.09M	-169.43M	-146.43M	-102.68M	-59.73M	-47.9M
Selling & General & Admin	264.12M	265.54M	220.21M	149.88M	135.8M	128.95M	103.65M	103.96M	98.02M
Research & Development	217.5M	244.99M	235.78M	210.33M	131.77M	140.96M	123.76M	78.17M	70.85M
Other Expenses	75.39M	n/a	974K	231K	1.42M	-314K	-474K	1.11M	-264K
Operating Expenses	557M	521.93M	455.99M	360.21M	267.57M	269.91M	227.41M	182.13M	168.87M
Interest Expense	11.18M	11.33M	11.28M	20.14M	19.05M	18.83M	9.81M	1.19M	34.48M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	557M	521.98M	463.58M	367M	273.7M	275.15M	232.94M	185.73M	173.42M
Income Tax Expense	120K	223K	313K	409K	-19.36M	-21K	811K	1.37M	-9.68M
Shares Outstanding (Basic)	78.89M	74.27M	63.76M	59.83M	47.54M	42.34M	40.42M	38.77M	37M
Shares Outstanding (Diluted)	78.89M	74.27M	63.76M	59.83M	47.54M	42.34M	40.43M	38.77M	38.29M
EPS (Basic)	-4.08	-1.5	-4.37	-3.01	-3.56	-3.46	-2.54	-1.54	-1.29
EPS (Diluted)	-4.08	-1.5	-4.37	-3.01	-3.56	-3.46	-2.54	-1.54	-1.25
EBITDA	-265.77M	-326.25M	-299.42M	-186.68M	-143.95M	-107.21M	-73.39M	-38.67M	-38.79M
EBIT	-309.33M	-364.78M	-320.14M	-197.2M	-169.74M	-127.62M	-92.06M	-53.94M	-52.85M
Depreciation & Amortization	43.55M	38.53M	20.72M	26.62M	25.79M	20.41M	18.67M	17.8M	16.14M